First Rounders: Ted Love

Nature Biotechnology, Published online: 10 July 2020; doi:10.1038/s41587-020-0617-xFirst Rounders: Ted Love

1h

First Rounders: Ted Love

3h

Danish bispecifics meet ADCs

Nature Biotechnology, Published online: 08 July 2020; doi:10.1038/s41587-020-0607-zDanish bispecifics meet ADCs

2d

Around the world in a month

Nature Biotechnology, Published online: 08 July 2020; doi:10.1038/s41587-020-0596-yAround the world in a month

2d

Microbiome therapeutics and patent protection

Nature Biotechnology, Published online: 08 July 2020; doi:10.1038/s41587-020-0579-zObtaining patent protection for microbiome therapeutics has been affected profoundly by the US Supreme Court decisions in Myriad and Mayo, which redefined the scope of which natural phenomena, including microbiome therapeutics, are patent eligible.

2d

A COVID-19 model

Nature Biotechnology, Published online: 08 July 2020; doi:10.1038/s41587-020-0606-0A COVID-19 model

2d

Gene editing

Nature Biotechnology, Published online: 08 July 2020; doi:10.1038/s41587-020-0599-8Recent patents related to CRISPR-based gene editing, disease treatment and methods for targeting nucleic acids.

2d

People

Nature Biotechnology, Published online: 08 July 2020; doi:10.1038/s41587-020-0594-0Recent moves of note in and around the biotech and pharma industries.

2d

Focus on CRISPR tools and therapies

Nature Biotechnology, Published online: 08 July 2020; doi:10.1038/s41587-020-0611-3Focus on CRISPR tools and therapies

2d

The clinical cutting edge

Nature Biotechnology, Published online: 08 July 2020; doi:10.1038/s41587-020-0612-2As CRISPR–Cas9 enters human testing, the blistering pace of progress in preclinical research is offering a bewildering array of options for therapeutic gene editing.

2d